We are live on ! Find out more
ATI

Act Two Investors Portfolio holdings

AUM $453M
1-Year Est. Return 10.9%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+10.9%
3 Year Est. Return
+52.85%
5 Year Est. Return
+67.7%
10 Year Est. Return
–
AUM
$498M
AUM Growth
+$34.9M
Cap. Flow
+$10.4M
Cap. Flow %
2.09%
Top 10 Hldgs %
69.16%
Holding
52
New
5
Increased
22
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$20.1M
2
GPC icon
Genuine Parts
GPC
+$17.5M
3
UNH icon
UnitedHealth
UNH
+$2.29M
4
SBUX icon
Starbucks
SBUX
+$1.13M
5
VGLT icon
Vanguard Long-Term Treasury ETF
VGLT
+$1.04M

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$18M
2
VZ icon
Verizon
VZ
+$9.39M
3
GEHC icon
GE HealthCare
GEHC
+$4.45M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.32M
5
NXPI icon
NXP Semiconductors
NXPI
+$793K

Sector Composition

Rank Sector Weight
1 Technology 23.75%
2 Communication Services 17.26%
3 Healthcare 13.34%
4 Financials 13.07%
5 Consumer Discretionary 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
51
Verizon
VZ
$195B
– –
-249,042
Closed -$9.39M
XLB icon
52
State Street Materials Select Sector SPDR ETF
XLB
$8.55B
– –
-8,196
Closed -$351K
1 2
3

Similar funds

FNB
Farmers National Bank Danville, Kentucky $453M AUM 19.46% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $453M AUM 12.19% 1-Year Est. Return
AA
Addison Advisors Middlebury, Vermont $452M AUM 14.62% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $454M AUM
TPWM
Twelve Points Wealth Management Concord, Massachusetts $455M AUM 19.98% 1-Year Est. Return
GSIAS
Garden State Investment Advisory Services Red Bank, New Jersey $455M AUM 25.41% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
CU
CDAM (UK) London, United Kingdom $451M AUM 6.84% 1-Year Est. Return

Act Two Investors's Q1 2024 Portfolio in Review

As of Q1 2024, Act Two Investors held 52 positions worth $498M, up 7.5% from $463M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Act Two Investors's Q1 2024 filing shows 5 new, 22 increased, 13 reduced and 4 closed positions. Its largest new stake was AstraZeneca: 151,729 shares worth $20.6M. The largest sale was Sysco, an estimated $18M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Communication Services and Healthcare.

  • Act Two Investors's largest Q1 2024 buy was AstraZeneca: 151,729 shares worth $20.6M.
  • Act Two Investors added most to UnitedHealth in Q1 2024, an estimated $2.29M increase.
  • Act Two Investors's biggest Q1 2024 reduction was GE HealthCare, cutting an estimated $4.45M.
  • Act Two Investors fully exited Sysco in Q1 2024, selling an estimated $18M.
  • Act Two Investors's ten largest holdings make up 69% of its $498M portfolio in Q1 2024.
  • Act Two Investors opened 5 new positions and closed 4 in Q1 2024.
  • Act Two Investors's portfolio value rose 7.5% quarter-over-quarter to $498M.

Based on Act Two Investors's 13F filing for Q1 2024, filed 9 May 2024.